Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The objectives of this study are to determine efficacy and safety of 0.75% topical capsaicin nanoparticle preparation versus placebo in patient with painful diabetic neuropathy.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Collaborator: Thailand Research Fund
• Treatments: Capsaicin

Criteria

Inclusion Criteria:

• History of type 2 Diabetes mellitus

• Peripheral neuropathy

• Stabilized on pain medication for at least one month

• No previous invasive intervention for pain relief

Exclusion Criteria:

• Local wound or any skin abnormality in the applicable area

• Allergic to capsaicin

• Refuse to participate or give consent

• Has other significant disease or receive medication that may worsen neuropathy